nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—ATM—melanoma	0.144	0.256	CbGaD
Caffeine—PIK3CB—melanoma	0.132	0.234	CbGaD
Caffeine—PIK3CD—melanoma	0.132	0.234	CbGaD
Caffeine—PIK3CA—melanoma	0.102	0.181	CbGaD
Caffeine—CYP1B1—melanoma	0.0416	0.0737	CbGaD
Caffeine—CYP1B1—Docetaxel—melanoma	0.029	0.136	CbGbCtD
Caffeine—CYP1A1—Dacarbazine—melanoma	0.0284	0.133	CbGbCtD
Caffeine—CYP2E1—Dacarbazine—melanoma	0.0219	0.103	CbGbCtD
Caffeine—CYP1A2—Carmustine—melanoma	0.0209	0.0982	CbGbCtD
Caffeine—CYP1A2—Vemurafenib—melanoma	0.0166	0.0777	CbGbCtD
Caffeine—CYP3A4—Temozolomide—melanoma	0.0158	0.0742	CbGbCtD
Caffeine—CYP2D6—Vemurafenib—melanoma	0.0136	0.064	CbGbCtD
Caffeine—CYP1A2—Dacarbazine—melanoma	0.0127	0.0595	CbGbCtD
Caffeine—ABCB1—melanoma	0.0119	0.0211	CbGaD
Caffeine—CYP3A7—Docetaxel—melanoma	0.0102	0.0477	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0102	0.0477	CbGbCtD
Caffeine—ABCB1—Dactinomycin—melanoma	0.00962	0.0451	CbGbCtD
Caffeine—CYP3A4—Vemurafenib—melanoma	0.00867	0.0407	CbGbCtD
Caffeine—CYP3A5—Docetaxel—melanoma	0.00763	0.0358	CbGbCtD
Caffeine—ABCB1—Docetaxel—melanoma	0.00497	0.0233	CbGbCtD
Caffeine—Necrotising enterocolitis neonatal—Docetaxel—melanoma	0.00329	0.101	CcSEcCtD
Caffeine—Necrotizing enterocolitis—Docetaxel—melanoma	0.00329	0.101	CcSEcCtD
Caffeine—CYP3A4—Docetaxel—melanoma	0.00298	0.014	CbGbCtD
Caffeine—Necrotising colitis—Docetaxel—melanoma	0.00269	0.0824	CcSEcCtD
Caffeine—PIK3CA—skin epidermis—melanoma	0.00251	0.0553	CbGeAlD
Caffeine—PIK3CD—endothelium—melanoma	0.00211	0.0465	CbGeAlD
Caffeine—PIK3CD—blood vessel—melanoma	0.00194	0.0428	CbGeAlD
Caffeine—PIK3CB—endothelium—melanoma	0.00184	0.0405	CbGeAlD
Caffeine—PIK3CA—endothelium—melanoma	0.00182	0.0401	CbGeAlD
Caffeine—PIK3CB—hair follicle—melanoma	0.00181	0.0398	CbGeAlD
Caffeine—PIK3CB—blood vessel—melanoma	0.0017	0.0374	CbGeAlD
Caffeine—PIK3CA—blood vessel—melanoma	0.00168	0.037	CbGeAlD
Caffeine—PIK3CD—neck—melanoma	0.00139	0.0306	CbGeAlD
Caffeine—Oxtriphylline—HDAC2—melanoma	0.00129	0.541	CrCbGaD
Caffeine—PIK3CB—neck—melanoma	0.00121	0.0267	CbGeAlD
Caffeine—PIK3CA—neck—melanoma	0.0012	0.0265	CbGeAlD
Caffeine—Impaired healing—Carmustine—melanoma	0.00112	0.0342	CcSEcCtD
Caffeine—PRKDC—eye—melanoma	0.0011	0.0243	CbGeAlD
Caffeine—PRKDC—retina—melanoma	0.00109	0.0241	CbGeAlD
Caffeine—PIK3CD—eye—melanoma	0.00103	0.0228	CbGeAlD
Caffeine—PIK3CD—retina—melanoma	0.00103	0.0226	CbGeAlD
Caffeine—ATM—skin of body—melanoma	0.00101	0.0224	CbGeAlD
Caffeine—PIK3CB—eye—melanoma	0.000902	0.0199	CbGeAlD
Caffeine—PIK3CD—skin of body—melanoma	0.0009	0.0198	CbGeAlD
Caffeine—PIK3CB—retina—melanoma	0.000894	0.0197	CbGeAlD
Caffeine—PIK3CA—eye—melanoma	0.000893	0.0197	CbGeAlD
Caffeine—PIK3CA—retina—melanoma	0.000885	0.0195	CbGeAlD
Caffeine—PRKDC—mammalian vulva—melanoma	0.000875	0.0193	CbGeAlD
Caffeine—Cerebral haemorrhage—Carmustine—melanoma	0.000872	0.0267	CcSEcCtD
Caffeine—Disseminated intravascular coagulation—Docetaxel—melanoma	0.000869	0.0266	CcSEcCtD
Caffeine—Cerebral haemorrhage—Temozolomide—melanoma	0.000843	0.0258	CcSEcCtD
Caffeine—PIK3CD—mammalian vulva—melanoma	0.000821	0.0181	CbGeAlD
Caffeine—PIK3CB—skin of body—melanoma	0.000785	0.0173	CbGeAlD
Caffeine—Theophylline—HDAC2—melanoma	0.00078	0.328	CrCbGaD
Caffeine—PIK3CA—skin of body—melanoma	0.000777	0.0171	CbGeAlD
Caffeine—PIK3CB—mammalian vulva—melanoma	0.000716	0.0158	CbGeAlD
Caffeine—PIK3CA—mammalian vulva—melanoma	0.000709	0.0156	CbGeAlD
Caffeine—RYR1—mammalian vulva—melanoma	0.000709	0.0156	CbGeAlD
Caffeine—ATM—head—melanoma	0.000662	0.0146	CbGeAlD
Caffeine—ADORA2B—eye—melanoma	0.000657	0.0145	CbGeAlD
Caffeine—Dry skin—Vemurafenib—melanoma	0.000608	0.0186	CcSEcCtD
Caffeine—CYP1B1—hair follicle—melanoma	0.0006	0.0132	CbGeAlD
Caffeine—CYP1A1—skin epidermis—melanoma	0.000594	0.0131	CbGeAlD
Caffeine—PIK3CD—head—melanoma	0.000587	0.0129	CbGeAlD
Caffeine—Accidental injury—Carmustine—melanoma	0.000546	0.0167	CcSEcCtD
Caffeine—ADORA2B—mammalian vulva—melanoma	0.000521	0.0115	CbGeAlD
Caffeine—PIK3CB—head—melanoma	0.000512	0.0113	CbGeAlD
Caffeine—Infestation—Vemurafenib—melanoma	0.000511	0.0156	CcSEcCtD
Caffeine—Infestation NOS—Vemurafenib—melanoma	0.000511	0.0156	CcSEcCtD
Caffeine—PIK3CA—head—melanoma	0.000507	0.0112	CbGeAlD
Caffeine—RYR1—head—melanoma	0.000507	0.0112	CbGeAlD
Caffeine—ATM—lymph node—melanoma	0.000464	0.0102	CbGeAlD
Caffeine—Haemoglobin decreased—Docetaxel—melanoma	0.000451	0.0138	CcSEcCtD
Caffeine—Sepsis—Dactinomycin—melanoma	0.000448	0.0137	CcSEcCtD
Caffeine—PRKDC—lymph node—melanoma	0.000438	0.00966	CbGeAlD
Caffeine—Injury—Bleomycin—melanoma	0.000437	0.0134	CcSEcCtD
Caffeine—Cardiac disorder—Vemurafenib—melanoma	0.000426	0.013	CcSEcCtD
Caffeine—Sepsis—Carmustine—melanoma	0.000419	0.0128	CcSEcCtD
Caffeine—PIK3CD—lymph node—melanoma	0.000411	0.00906	CbGeAlD
Caffeine—Malnutrition—Vemurafenib—melanoma	0.000399	0.0122	CcSEcCtD
Caffeine—Injury—Carmustine—melanoma	0.000381	0.0117	CcSEcCtD
Caffeine—Deafness—Temozolomide—melanoma	0.000379	0.0116	CcSEcCtD
Caffeine—ADORA2B—head—melanoma	0.000373	0.00822	CbGeAlD
Caffeine—PIK3CB—lymph node—melanoma	0.000359	0.0079	CbGeAlD
Caffeine—PIK3CA—lymph node—melanoma	0.000355	0.00782	CbGeAlD
Caffeine—Gastrointestinal haemorrhage—Carmustine—melanoma	0.000351	0.0107	CcSEcCtD
Caffeine—Infection—Vemurafenib—melanoma	0.000324	0.0099	CcSEcCtD
Caffeine—Nervous system disorder—Vemurafenib—melanoma	0.00032	0.00977	CcSEcCtD
Caffeine—Skin disorder—Vemurafenib—melanoma	0.000317	0.00968	CcSEcCtD
Caffeine—Theophylline—CYP1B1—melanoma	0.000311	0.131	CrCbGaD
Caffeine—Dry skin—Temozolomide—melanoma	0.000311	0.0095	CcSEcCtD
Caffeine—ADORA2A—head—melanoma	0.00031	0.00684	CbGeAlD
Caffeine—CYP1B1—eye—melanoma	0.000299	0.00659	CbGeAlD
Caffeine—Gastrointestinal disorder—Vemurafenib—melanoma	0.000281	0.0086	CcSEcCtD
Caffeine—Haemoglobin—Bleomycin—melanoma	0.000279	0.00854	CcSEcCtD
Caffeine—Haemorrhage—Bleomycin—melanoma	0.000278	0.0085	CcSEcCtD
Caffeine—PDE4B—mammalian vulva—melanoma	0.000277	0.00611	CbGeAlD
Caffeine—Pulmonary oedema—Docetaxel—melanoma	0.000276	0.00845	CcSEcCtD
Caffeine—Hyperglycaemia—Carmustine—melanoma	0.000273	0.00836	CcSEcCtD
Caffeine—Sepsis—Docetaxel—melanoma	0.000269	0.00824	CcSEcCtD
Caffeine—ADORA1—head—melanoma	0.000268	0.00591	CbGeAlD
Caffeine—Renal failure—Carmustine—melanoma	0.000266	0.00812	CcSEcCtD
Caffeine—Hyperglycaemia—Temozolomide—melanoma	0.000264	0.00808	CcSEcCtD
Caffeine—Infestation—Temozolomide—melanoma	0.000261	0.00798	CcSEcCtD
Caffeine—Infestation NOS—Temozolomide—melanoma	0.000261	0.00798	CcSEcCtD
Caffeine—CYP1B1—skin of body—melanoma	0.00026	0.00574	CbGeAlD
Caffeine—Deafness—Docetaxel—melanoma	0.000252	0.0077	CcSEcCtD
Caffeine—Haemoglobin—Carmustine—melanoma	0.000244	0.00746	CcSEcCtD
Caffeine—Haemorrhage—Carmustine—melanoma	0.000243	0.00742	CcSEcCtD
Caffeine—Hypersensitivity—Vemurafenib—melanoma	0.00024	0.00734	CcSEcCtD
Caffeine—Haemoglobin—Temozolomide—melanoma	0.000236	0.0072	CcSEcCtD
Caffeine—Haemorrhage—Temozolomide—melanoma	0.000234	0.00717	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000225	0.00689	CcSEcCtD
Caffeine—Cardiac disorder—Temozolomide—melanoma	0.000218	0.00665	CcSEcCtD
Caffeine—Immune system disorder—Temozolomide—melanoma	0.000212	0.00647	CcSEcCtD
Caffeine—Malnutrition—Carmustine—melanoma	0.000211	0.00646	CcSEcCtD
Caffeine—Dry skin—Docetaxel—melanoma	0.000207	0.00632	CcSEcCtD
Caffeine—ABCB1—blood vessel—melanoma	0.000206	0.00455	CbGeAlD
Caffeine—Rash—Vemurafenib—melanoma	0.000205	0.00628	CcSEcCtD
Caffeine—Dermatitis—Vemurafenib—melanoma	0.000205	0.00628	CcSEcCtD
Caffeine—Malnutrition—Temozolomide—melanoma	0.000204	0.00624	CcSEcCtD
Caffeine—PDE4B—head—melanoma	0.000198	0.00437	CbGeAlD
Caffeine—Infection—Bleomycin—melanoma	0.000196	0.006	CcSEcCtD
Caffeine—Agitation—Carmustine—melanoma	0.000194	0.00593	CcSEcCtD
Caffeine—ADORA1—lymph node—melanoma	0.000188	0.00413	CbGeAlD
Caffeine—Agitation—Temozolomide—melanoma	0.000188	0.00573	CcSEcCtD
Caffeine—CYP1A1—skin of body—melanoma	0.000184	0.00406	CbGeAlD
Caffeine—Convulsion—Carmustine—melanoma	0.000183	0.00559	CcSEcCtD
Caffeine—Infection—Dactinomycin—melanoma	0.000183	0.00559	CcSEcCtD
Caffeine—Hypertension—Carmustine—melanoma	0.000182	0.00557	CcSEcCtD
Caffeine—Convulsion—Temozolomide—melanoma	0.000177	0.00541	CcSEcCtD
Caffeine—Hypertension—Temozolomide—melanoma	0.000176	0.00539	CcSEcCtD
Caffeine—Dyspnoea—Bleomycin—melanoma	0.000176	0.00538	CcSEcCtD
Caffeine—Infestation NOS—Docetaxel—melanoma	0.000174	0.00531	CcSEcCtD
Caffeine—Infestation—Docetaxel—melanoma	0.000174	0.00531	CcSEcCtD
Caffeine—Infection—Carmustine—melanoma	0.000171	0.00524	CcSEcCtD
Caffeine—Renal failure—Docetaxel—melanoma	0.000171	0.00522	CcSEcCtD
Caffeine—CYP1B1—head—melanoma	0.00017	0.00374	CbGeAlD
Caffeine—Tachycardia—Carmustine—melanoma	0.000168	0.00514	CcSEcCtD
Caffeine—CYP1A1—mammalian vulva—melanoma	0.000168	0.0037	CbGeAlD
Caffeine—Infection—Temozolomide—melanoma	0.000165	0.00506	CcSEcCtD
Caffeine—Nervous system disorder—Temozolomide—melanoma	0.000163	0.00499	CcSEcCtD
Caffeine—Skin disorder—Temozolomide—melanoma	0.000162	0.00495	CcSEcCtD
Caffeine—Haemoglobin—Docetaxel—melanoma	0.000157	0.00479	CcSEcCtD
Caffeine—Haemorrhage—Docetaxel—melanoma	0.000156	0.00477	CcSEcCtD
Caffeine—Dyspnoea—Carmustine—melanoma	0.000154	0.0047	CcSEcCtD
Caffeine—Gastrointestinal disorder—Carmustine—melanoma	0.000149	0.00455	CcSEcCtD
Caffeine—Dyspnoea—Temozolomide—melanoma	0.000148	0.00454	CcSEcCtD
Caffeine—Hypersensitivity—Bleomycin—melanoma	0.000145	0.00445	CcSEcCtD
Caffeine—Cardiac disorder—Docetaxel—melanoma	0.000145	0.00442	CcSEcCtD
Caffeine—Gastrointestinal disorder—Temozolomide—melanoma	0.000144	0.0044	CcSEcCtD
Caffeine—Immune system disorder—Docetaxel—melanoma	0.000141	0.00431	CcSEcCtD
Caffeine—PDE4B—lymph node—melanoma	0.000139	0.00306	CbGeAlD
Caffeine—Malnutrition—Docetaxel—melanoma	0.000136	0.00415	CcSEcCtD
Caffeine—Hypersensitivity—Dactinomycin—melanoma	0.000136	0.00415	CcSEcCtD
Caffeine—Hypersensitivity—Carmustine—melanoma	0.000127	0.00388	CcSEcCtD
Caffeine—Rash—Bleomycin—melanoma	0.000124	0.00381	CcSEcCtD
Caffeine—Dermatitis—Bleomycin—melanoma	0.000124	0.0038	CcSEcCtD
Caffeine—Hypersensitivity—Temozolomide—melanoma	0.000123	0.00375	CcSEcCtD
Caffeine—CYP1A1—head—melanoma	0.00012	0.00265	CbGeAlD
Caffeine—CYP1B1—lymph node—melanoma	0.000119	0.00262	CbGeAlD
Caffeine—Convulsion—Docetaxel—melanoma	0.000118	0.0036	CcSEcCtD
Caffeine—Hypertension—Docetaxel—melanoma	0.000117	0.00358	CcSEcCtD
Caffeine—Rash—Dactinomycin—melanoma	0.000116	0.00355	CcSEcCtD
Caffeine—Infection—Docetaxel—melanoma	0.00011	0.00336	CcSEcCtD
Caffeine—CYP2E1—head—melanoma	0.00011	0.00241	CbGeAlD
Caffeine—ABCB1—retina—melanoma	0.000109	0.0024	CbGeAlD
Caffeine—Rash—Carmustine—melanoma	0.000109	0.00332	CcSEcCtD
Caffeine—Nervous system disorder—Docetaxel—melanoma	0.000109	0.00332	CcSEcCtD
Caffeine—Dermatitis—Carmustine—melanoma	0.000109	0.00332	CcSEcCtD
Caffeine—Tachycardia—Docetaxel—melanoma	0.000108	0.00331	CcSEcCtD
Caffeine—Skin disorder—Docetaxel—melanoma	0.000108	0.00329	CcSEcCtD
Caffeine—Rash—Temozolomide—melanoma	0.000105	0.00321	CcSEcCtD
Caffeine—Dermatitis—Temozolomide—melanoma	0.000105	0.00321	CcSEcCtD
Caffeine—Dyspnoea—Docetaxel—melanoma	9.87e-05	0.00302	CcSEcCtD
Caffeine—Gastrointestinal disorder—Docetaxel—melanoma	9.56e-05	0.00292	CcSEcCtD
Caffeine—ABCB1—mammalian vulva—melanoma	8.72e-05	0.00192	CbGeAlD
Caffeine—CYP2D6—head—melanoma	8.67e-05	0.00191	CbGeAlD
Caffeine—CYP1A1—lymph node—melanoma	8.41e-05	0.00185	CbGeAlD
Caffeine—Hypersensitivity—Docetaxel—melanoma	8.16e-05	0.0025	CcSEcCtD
Caffeine—Rash—Docetaxel—melanoma	6.98e-05	0.00214	CcSEcCtD
Caffeine—Dermatitis—Docetaxel—melanoma	6.98e-05	0.00213	CcSEcCtD
Caffeine—ABCB1—head—melanoma	6.24e-05	0.00137	CbGeAlD
Caffeine—ABCB1—lymph node—melanoma	4.37e-05	0.000963	CbGeAlD
Caffeine—CYP3A5—Metabolism—ABCB1—melanoma	1.02e-06	7.21e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3CG—melanoma	1.02e-06	7.19e-06	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—HRAS—melanoma	1.02e-06	7.19e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—STAT3—melanoma	1.02e-06	7.15e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.01e-06	7.14e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—SLC5A5—melanoma	1.01e-06	7.13e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—NRAS—melanoma	1.01e-06	7.13e-06	CbGpPWpGaD
Caffeine—PIK3CA—Disease—HRAS—melanoma	1e-06	7.05e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9.99e-07	7.03e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PIK3CD—melanoma	9.96e-07	7.01e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GNA11—melanoma	9.93e-07	6.98e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CXCL8—melanoma	9.87e-07	6.94e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PPARG—melanoma	9.86e-07	6.94e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GNA11—melanoma	9.84e-07	6.92e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—ALB—melanoma	9.83e-07	6.92e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—MAPK3—melanoma	9.82e-07	6.91e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—HRAS—melanoma	9.81e-07	6.9e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GNAQ—melanoma	9.79e-07	6.89e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CD44—melanoma	9.79e-07	6.89e-06	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—IL6—melanoma	9.78e-07	6.88e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—FASN—melanoma	9.72e-07	6.83e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—VEGFA—melanoma	9.71e-07	6.83e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MAPK3—melanoma	9.71e-07	6.83e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ABCB1—melanoma	9.68e-07	6.81e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.64e-07	6.78e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CDKN1B—melanoma	9.64e-07	6.78e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—FASN—melanoma	9.63e-07	6.77e-06	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—PIK3CA—melanoma	9.63e-07	6.77e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—STAT3—melanoma	9.62e-07	6.76e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—NRAS—melanoma	9.59e-07	6.75e-06	CbGpPWpGaD
Caffeine—PIK3CA—Disease—IL6—melanoma	9.59e-07	6.75e-06	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—AKT1—melanoma	9.59e-07	6.74e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—SLC5A5—melanoma	9.56e-07	6.72e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—MYC—melanoma	9.55e-07	6.72e-06	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—PIK3CA—melanoma	9.54e-07	6.71e-06	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—AKT1—melanoma	9.54e-07	6.71e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	9.51e-07	6.69e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—SLC5A5—melanoma	9.47e-07	6.66e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PRKCA—melanoma	9.45e-07	6.65e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CASP3—melanoma	9.45e-07	6.65e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MYC—melanoma	9.44e-07	6.64e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IL2—melanoma	9.43e-07	6.64e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PRKCA—melanoma	9.43e-07	6.63e-06	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—AKT1—melanoma	9.41e-07	6.62e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CYP1B1—melanoma	9.39e-07	6.6e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—IL6—melanoma	9.39e-07	6.6e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—ERCC2—melanoma	9.37e-07	6.59e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—ERCC2—melanoma	9.35e-07	6.58e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—MAPK1—melanoma	9.35e-07	6.57e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—EGFR—melanoma	9.35e-07	6.57e-06	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TP53—melanoma	9.31e-07	6.55e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MAPK1—melanoma	9.24e-07	6.5e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—EGFR—melanoma	9.23e-07	6.5e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GNAQ—melanoma	9.23e-07	6.49e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CD44—melanoma	9.23e-07	6.49e-06	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TP53—melanoma	9.23e-07	6.49e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CCND1—melanoma	9.2e-07	6.47e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MAPK3—melanoma	9.19e-07	6.46e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GNAQ—melanoma	9.15e-07	6.44e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CD44—melanoma	9.15e-07	6.44e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CTNNB1—melanoma	9.11e-07	6.41e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PLA2G6—melanoma	9.07e-07	6.38e-06	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—AKT1—melanoma	9.02e-07	6.35e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3CD—melanoma	8.98e-07	6.32e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.96e-07	6.3e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MYC—melanoma	8.94e-07	6.29e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MMP9—melanoma	8.93e-07	6.28e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PRKCA—melanoma	8.91e-07	6.27e-06	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—HRAS—melanoma	8.91e-07	6.27e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYP17A1—melanoma	8.91e-07	6.26e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CDKN1A—melanoma	8.9e-07	6.26e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.88e-07	6.24e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PTEN—melanoma	8.88e-07	6.24e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ABCB1—melanoma	8.88e-07	6.24e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—ALB—melanoma	8.87e-07	6.24e-06	CbGpPWpGaD
Caffeine—PIK3CA—Disease—AKT1—melanoma	8.85e-07	6.23e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CYP1B1—melanoma	8.85e-07	6.22e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ERCC2—melanoma	8.84e-07	6.22e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—NFKB1—melanoma	8.83e-07	6.21e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—KRAS—melanoma	8.83e-07	6.21e-06	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—HRAS—melanoma	8.83e-07	6.21e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.78e-07	6.18e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CYP1B1—melanoma	8.77e-07	6.17e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MAPK1—melanoma	8.74e-07	6.15e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—EGFR—melanoma	8.74e-07	6.15e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—KRAS—melanoma	8.72e-07	6.14e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PIK3CB—melanoma	8.68e-07	6.11e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	8.67e-07	6.1e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—AKT1—melanoma	8.66e-07	6.09e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PTGS2—melanoma	8.6e-07	6.05e-06	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—IL6—melanoma	8.52e-07	6e-06	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—IL6—melanoma	8.45e-07	5.94e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GNA11—melanoma	8.41e-07	5.92e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—KRAS—melanoma	8.26e-07	5.81e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—FASN—melanoma	8.23e-07	5.79e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PRKCA—melanoma	8.17e-07	5.75e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—VCAN—melanoma	8.15e-07	5.73e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—PIK3CA—melanoma	8.11e-07	5.71e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ERCC2—melanoma	8.1e-07	5.7e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—SLC5A5—melanoma	8.1e-07	5.69e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—VEGFA—melanoma	8.02e-07	5.64e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—PIK3CA—melanoma	8.01e-07	5.64e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—STAT3—melanoma	7.94e-07	5.58e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—NRAS—melanoma	7.92e-07	5.57e-06	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—AKT1—melanoma	7.86e-07	5.53e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TP53—melanoma	7.85e-07	5.52e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3CB—melanoma	7.83e-07	5.51e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GNAQ—melanoma	7.82e-07	5.5e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CD44—melanoma	7.82e-07	5.5e-06	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—AKT1—melanoma	7.79e-07	5.48e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTGS2—melanoma	7.76e-07	5.46e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TP53—melanoma	7.75e-07	5.45e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.74e-07	5.45e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.66e-07	5.39e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.59e-07	5.34e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MAPK3—melanoma	7.58e-07	5.33e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—HRAS—melanoma	7.5e-07	5.28e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PTEN—melanoma	7.5e-07	5.28e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYP1B1—melanoma	7.5e-07	5.27e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—HRAS—melanoma	7.42e-07	5.22e-06	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—AKT1—melanoma	7.41e-07	5.21e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CG—melanoma	7.4e-07	5.21e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CG—melanoma	7.39e-07	5.2e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MYC—melanoma	7.38e-07	5.19e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TP53—melanoma	7.34e-07	5.16e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.32e-07	5.15e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ABCB1—melanoma	7.29e-07	5.13e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ABCB1—melanoma	7.22e-07	5.08e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MAPK1—melanoma	7.22e-07	5.08e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—EGFR—melanoma	7.22e-07	5.08e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—IL6—melanoma	7.18e-07	5.05e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PPARG—melanoma	7.14e-07	5.03e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PPARG—melanoma	7.13e-07	5.01e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PRKCA—melanoma	7.12e-07	5.01e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—IL6—melanoma	7.1e-07	4.99e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ERCC2—melanoma	7.06e-07	4.96e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—HRAS—melanoma	7.02e-07	4.94e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CG—melanoma	6.98e-07	4.91e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP17A1—melanoma	6.87e-07	4.83e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—KRAS—melanoma	6.82e-07	4.79e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTEN—melanoma	6.77e-07	4.76e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PPARG—melanoma	6.74e-07	4.74e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—IL6—melanoma	6.72e-07	4.73e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.71e-07	4.72e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PRKCA—melanoma	6.71e-07	4.72e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ERCC2—melanoma	6.65e-07	4.68e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PRKCA—melanoma	6.65e-07	4.68e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—AKT1—melanoma	6.63e-07	4.66e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.62e-07	4.65e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ERCC2—melanoma	6.59e-07	4.64e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—AKT1—melanoma	6.55e-07	4.61e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CD—melanoma	6.51e-07	4.58e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CD—melanoma	6.49e-07	4.57e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GNA11—melanoma	6.49e-07	4.57e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—ALB—melanoma	6.42e-07	4.52e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—ALB—melanoma	6.41e-07	4.51e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CG—melanoma	6.4e-07	4.5e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—FASN—melanoma	6.35e-07	4.47e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PIK3CA—melanoma	6.26e-07	4.4e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—SLC5A5—melanoma	6.25e-07	4.39e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—AKT1—melanoma	6.2e-07	4.36e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PPARG—melanoma	6.18e-07	4.34e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ABCB1—melanoma	6.17e-07	4.34e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CD—melanoma	6.14e-07	4.32e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TP53—melanoma	6.06e-07	4.26e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ALB—melanoma	6.06e-07	4.26e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GNAQ—melanoma	6.03e-07	4.24e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CD44—melanoma	6.03e-07	4.24e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—HRAS—melanoma	5.79e-07	4.08e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP1B1—melanoma	5.79e-07	4.07e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PRKCA—melanoma	5.68e-07	4e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CB—melanoma	5.67e-07	3.99e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CB—melanoma	5.66e-07	3.98e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ERCC2—melanoma	5.63e-07	3.96e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CD—melanoma	5.62e-07	3.96e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTGS2—melanoma	5.62e-07	3.95e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTGS2—melanoma	5.61e-07	3.94e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CG—melanoma	5.57e-07	3.92e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ALB—melanoma	5.55e-07	3.91e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IL6—melanoma	5.55e-07	3.9e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.46e-07	3.84e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PPARG—melanoma	5.38e-07	3.78e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CB—melanoma	5.35e-07	3.76e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTGS2—melanoma	5.3e-07	3.73e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PIK3CA—melanoma	5.29e-07	3.72e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CG—melanoma	5.25e-07	3.69e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CG—melanoma	5.21e-07	3.66e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—AKT1—melanoma	5.12e-07	3.6e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PPARG—melanoma	5.07e-07	3.57e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PPARG—melanoma	5.03e-07	3.54e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CB—melanoma	4.9e-07	3.45e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTEN—melanoma	4.9e-07	3.45e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CD—melanoma	4.9e-07	3.45e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTEN—melanoma	4.89e-07	3.44e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTGS2—melanoma	4.86e-07	3.42e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ALB—melanoma	4.84e-07	3.4e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3CA—melanoma	4.77e-07	3.36e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ABCB1—melanoma	4.76e-07	3.35e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.67e-07	3.28e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTEN—melanoma	4.62e-07	3.25e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CD—melanoma	4.62e-07	3.25e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CD—melanoma	4.58e-07	3.22e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ALB—melanoma	4.56e-07	3.21e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ALB—melanoma	4.52e-07	3.18e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CG—melanoma	4.45e-07	3.13e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PRKCA—melanoma	4.38e-07	3.08e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ERCC2—melanoma	4.35e-07	3.06e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—AKT1—melanoma	4.32e-07	3.04e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PPARG—melanoma	4.29e-07	3.02e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CB—melanoma	4.27e-07	3e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTEN—melanoma	4.24e-07	2.98e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTGS2—melanoma	4.23e-07	2.98e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CB—melanoma	4.02e-07	2.83e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CB—melanoma	3.99e-07	2.81e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTGS2—melanoma	3.99e-07	2.81e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTGS2—melanoma	3.95e-07	2.78e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CD—melanoma	3.91e-07	2.75e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—AKT1—melanoma	3.9e-07	2.74e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ALB—melanoma	3.86e-07	2.72e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTEN—melanoma	3.69e-07	2.6e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTEN—melanoma	3.48e-07	2.45e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CA—melanoma	3.46e-07	2.43e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CA—melanoma	3.45e-07	2.43e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTEN—melanoma	3.45e-07	2.43e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CG—melanoma	3.43e-07	2.42e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CB—melanoma	3.41e-07	2.4e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTGS2—melanoma	3.38e-07	2.38e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PPARG—melanoma	3.31e-07	2.33e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CA—melanoma	3.26e-07	2.29e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CD—melanoma	3.02e-07	2.12e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CA—melanoma	2.99e-07	2.1e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ALB—melanoma	2.98e-07	2.1e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTEN—melanoma	2.95e-07	2.07e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—AKT1—melanoma	2.82e-07	1.99e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—AKT1—melanoma	2.82e-07	1.98e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—AKT1—melanoma	2.66e-07	1.87e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CB—melanoma	2.63e-07	1.85e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTGS2—melanoma	2.61e-07	1.83e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CA—melanoma	2.6e-07	1.83e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CA—melanoma	2.45e-07	1.73e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—AKT1—melanoma	2.44e-07	1.72e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CA—melanoma	2.43e-07	1.71e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTEN—melanoma	2.27e-07	1.6e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—AKT1—melanoma	2.13e-07	1.5e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CA—melanoma	2.08e-07	1.46e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—AKT1—melanoma	2e-07	1.41e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—AKT1—melanoma	1.99e-07	1.4e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—AKT1—melanoma	1.7e-07	1.19e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CA—melanoma	1.6e-07	1.13e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—AKT1—melanoma	1.31e-07	9.22e-07	CbGpPWpGaD
